KLI

Trastuzumab emtansine plus atezolizumab versus trastuzumab emtansine plus placebo in previously treated, HER2-positive advanced breast cancer (KATE2): a phase 2, multicentre, randomised, double-blind trial

Metadata Downloads
Publisher
LANCET ONCOLOGY
Language
영어
ISSN
1470-2045
Citation Volume
21
Citation Number
10
Citation Start Page
1283
Citation End Page
1295
Appears in Collections:
Medicine > Medicine
Authorize & License
  • Authorize공개
Files in This Item:
  • There are no files associated with this item.

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.